Neuroprotection Exploratory Trials in Parkinson's Disease: NET-PD

National Institute of Neurological Disorders and Stroke logo
National Institutes of Health
[About NET-PD]
[NET-PD Studies]
[Study news publications]
[For more information, call toll free 1-800-352-9424 email or visit] Parkinsons Web website
[Parkinson's Study]
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit Updates regarding government operating status and resumption of normal operations can be found at

NIH Exploratory Trials in Parkinson’s Disease (NET-PD) is a series of clinical research studies funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, that were conducted to find drugs to slow the progression of PD.

Current PD therapies are able to effectively treat symptoms,
however, over time, these therapies may be less effective and the disease process continues. Therefore it is important to identify agents that are able to slow disease progression.

[Participating in a clinical study allows you to play an active role in developing future treatments for Parkinson's disease.]

For current PD studies, visit

About NET-PD | NET-PD Studies | Study News and Publications
Privacy and confidentiality | FOIA | NINDS Home | Download Adobe Reader

U.S. Department of Health and Human Services logo     National Institutes of Health logo logo

NIH...Turning Discovery Into Health®